Use of a radioactively labelled molecule specifically...

Details Use of a radioactively labelled molecule specifically... Use of a radioactively labelled molecule specifically...

C - Chemistry, Metallurgy

07

K

C07K 16/18 (2006.01) A61K 51/10 (2006.01)

Patent

CA 2723323

The invention relates to the use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of treatment for patients with Hodgkin lymphoma, in particular primary refractory Hodgkin lymphoma or recurrent Hodgkin lymphoma after chemotherapy, and for Hodgkin lymphoma patients scheduled for primary combined modality therapy.

L'invention porte sur l'utilisation d'une molécule marquée de façon radioactive se fixant spécifiquement à la fibronectine ED-B dans un procédé de traitement pour des patients souffrant d'un lymphome hodgkinien, en particulier d'un lymphome hodgkinien réfractaire primaire ou d'un lymphome hodgkinien récidivant après chimiothérapie, et pour des patients souffrant d'un lymphome hodgkinien pour lesquels une thérapie combinée primaire est programmée.

Affiliated with

Also associated with

Rating

Use of a radioactively labelled molecule specifically... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a radioactively labelled molecule specifically..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a radioactively labelled molecule specifically... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1693300